Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Cell Mediated Immunity”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableLooking for participantsNCT06639854
What this trial is testing

The Use of Cytomegalovirus Cell Mediated Immunity to Optimize the Duration of Letermovir Prophylaxis in Hematopoietic Cell Transplant Recipients

Who this might be right for
Cytomegalovirus Cell Mediated ImmunityHematopoietic Cell Transplant
M.D. Anderson Cancer Center 105
Not applicableStudy completedNCT02538172
What this trial is testing

Cell-mediated Immunity for Prevention of CMV Disease

Who this might be right for
Cytomegalovirus Infections
University of Lausanne Hospitals 195
Not applicableStudy completedNCT02630537
What this trial is testing

Validation of Lophius Kits T-Track® CMV and T-Track® EBV in Hemodialysis Patients

Who this might be right for
Renal Failure Chronic Requiring Dialysis
Lophius Biosciences GmbH 133
Not applicableStudy completedNCT00815165
What this trial is testing

Cytomegalovirus Cell-Mediated Immunity

Who this might be right for
Cytomegalovirus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 165
Not applicableStudy completedNCT00716911
What this trial is testing

Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
City of Hope Medical Center 100
Not applicableStudy completedNCT01558037
What this trial is testing

Cell Mediated Immunity With Risk of Cytomegalovirus (CMV) in Solid Organ Transplant Recipients

Who this might be right for
Awaiting Organ TransplantInfection in Solid Organ Transplant Recipients
Michael Ison 113
Not applicableNot Yet RecruitingNCT06814301
What this trial is testing

Impact of CMV-Specific Immune Reconstitution at the End of Letermovir Prophylaxis on the Development of Late Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Recipients (INMUNOEND)

Who this might be right for
Cytomegalovirus Cell Mediated ImmunityStem Cell Transplantation, Hematopoietic
Maimónides Biomedical Research Institute of Córdoba 123
Not applicableStudy completedNCT02156479
What this trial is testing

Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients

Who this might be right for
Cytomegalovirus InfectionGVHD
Lophius Biosciences GmbH 175
Not applicableStudy completedNCT00001531
What this trial is testing

Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

Who this might be right for
Arterial Occlusive DiseasesAtherosclerosisCoronary Disease+1 more
National Heart, Lung, and Blood Institute (NHLBI) 355
Not applicableUnknownNCT01397058
What this trial is testing

Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress

Who this might be right for
Cytomegalovirus ViraemiaStress, PhysiologicalReceptor, Hormonal; Disorder+1 more
University of Athens 275
Not applicableStudy completedNCT03916497
What this trial is testing

Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients

Who this might be right for
Quantiferon-CMVCytomegalovirus InfectionsKidney Transplant Infection+1 more
University Hospital, Grenoble 60
Not applicableStudy completedNCT00699868
What this trial is testing

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients

Who this might be right for
Cytomegalovirus Infection
Assistance Publique Hopitaux De Marseille 29
Testing effectiveness (Phase 2)Study completedNCT00001890
What this trial is testing

Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections

Who this might be right for
AtherosclerosisChlamydia InfectionsCytomegalovirus Infections+2 more
National Heart, Lung, and Blood Institute (NHLBI) 80
Large-scale testing (Phase 3)Study completedNCT03123627
What this trial is testing

Randomized Clinical Trial, Open, Multicenter Parallel, no Suspension Inferiority Prophylactic Treatment With Valganciclovir in Kidney Transplant CMV-seropositive Cellular Immunity to Develop CD8 + CMV-specific Treatment After Induction Thymoglobulin.

Who this might be right for
Kidney Transplant Infection
Maimónides Biomedical Research Institute of Córdoba 150
Not applicableStudy completedNCT02784756
What this trial is testing

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Viraemia
University Health Network, Toronto 134
Not applicableStudy completedNCT02370758
What this trial is testing

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients

Who this might be right for
Cytomegalovirus Viraemia
University Health Network, Toronto 32
Not applicableEnded earlyNCT02064699
What this trial is testing

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test.

Who this might be right for
Renal Transplant RecipientImmunized Against the Cytomegalovirus
University Hospital, Limoges 75
Not applicableStudy completedNCT02083042
What this trial is testing

Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Kidney Transplant Recipients

Who this might be right for
CytomegalovirusKidney TransplantationCMV Specific Immune Response
Lophius Biosciences GmbH 97